Sinuva Sinus Implant is specifically designed to treat patients that suffer from recurring nasal polyps. “Nasal polyps are one of the most persistent and troublesome conditions that we see in our practice,” said Dr. Farhad Sigari. “Even when we surgically remove nasal polyps and the patient exercises ongoing care using steroid sprays or pills, they can return time and time again.” The Sinuva sinus implant directly addresses this problem. Sinuva releases mometasone furoate, a corticosteroid, to reduce inflammation directly at the polyp. The device is made from bioabsorbable polymers designed to soften over time. As the implant softens and polyps decrease, the implant may be expelled out of the nose on its own or the implant can be removed after 90 days or earlier at the physician’s discretion without hospitalization or surgery.
What are Nasal Polyps
Nasal polyps are noncancerous, inflammatory growths along the lining of the nasal passages. These growths may cause life-affecting symptoms including nasal discharge, congestion, facial pain, and a loss of sense of smell. Many people return to their sinus doctor with recurring polyps even after undergoing previous ethmoid sinus surgery.
What is SINUVA? What are the benefits and risks?
- Approved by the FDA in December 2017, SINUVA is an innovative treatment for adults with nasal polyps who have had previous ethmoid sinus surgery.
- The SINUVA sinus implant expands into the sinus opening and delivers an anti-inflammatory steroid directly to the site of polyp disease for up to 90 days.
- Placed during a routine office visit, SINUVA provides a less invasive treatment option for adults with recurrent nasal polyps who might otherwise warrant repeat surgical procedures.
- The safety and efficacy of the SINUVA Sinus Implant was evaluated in 400 patients, including 300 patients from the pivotal RESOLVE II study. The efficacy of SINUVA is based on the RESOLVE II study.
Contact Del Rey Sinus to see if Sinuva is right for you.
Call for appointment: (310) 823-4444
Sinuva Study Results
The first patient treated by Del Rey Sinus & Allergy Institute is a 53-year-old male who has had several previous sinus procedures, but had recurrence of difficult-to-treat polyps. Dr. Sigari notes that the implant was inserted easily and without complications, and the patient evidenced no discomfort. On subsequent follow-up, the sinuses showed no signs of irritation, infection or bleeding and the implant was working very nicely. The implant is designed to stay in place for up to 3 months, giving the patient continued localized treatment while minimizing systemic effects.
Positive data from the SINUVA Sinus Implant was supported by the results of the RESOLVE II pivotal study. The study demonstrated a reduction in polyps, nasal obstruction/congestion, a reduction in need for repeat sinus surgery, and an improvement in impaired sense of smell.